Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Ampicillin
Drug ID BADD_D00133
Description Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Indications and Usage For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
Marketing Status approved; vet_approved
ATC Code J01CA01; S01AA19
DrugBank ID DB00415
KEGG ID D00204
MeSH ID D000667
PubChem ID 6249
TTD Drug ID D0YA9Z
NDC Product Code 0781-2145; 82449-512; 0781-2144; 66794-221; 66794-222; 67457-351; 67457-352; 70518-2607; 44567-104; 66794-223; 71872-7240; 82449-902; 44567-101; 44567-103; 82449-511; 71872-7249; 25021-136; 44567-102; 51662-1560; 66794-220; 72572-017; 82449-903; 25021-137; 51662-1595; 66794-224; 72572-016
UNII 7C782967RD
Synonyms Ampicillin | Aminobenzylpenicillin | Penicillin, Aminobenzyl | Aminobenzyl Penicillin | Ampicillin Sodium | Sodium, Ampicillin | Ampicillin Trihydrate | Trihydrate, Ampicillin | Antibiotic KS-R1 | Antibiotic KS R1 | KS-R1, Antibiotic | Pentrexyl | Polycillin | Ukapen | Amcill | Omnipen
Chemical Information
Molecular Formula C16H19N3O4S
CAS Registry Number 69-53-4
SMILES CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Gastrointestinal disorder07.11.01.0010.001717%Not Available
Generalised oedema14.05.06.007; 08.01.07.004--
Glossitis07.14.01.001--Not Available
Hyperpyrexia08.05.02.002--Not Available
Hypersensitivity10.01.03.003--
Hyperventilation19.01.02.004; 22.02.01.006--Not Available
Laryngeal oedema23.04.01.005; 22.04.02.001; 10.01.05.003--
Laryngospasm22.04.02.002--
Leukopenia01.02.02.001--Not Available
Lymphadenopathy01.09.01.002--Not Available
Melaena24.07.02.013; 07.12.02.004--Not Available
Nausea07.01.07.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema mouth23.04.01.008; 10.01.05.006; 07.05.04.001--Not Available
Oral pain07.05.05.034--
Periorbital oedema23.04.01.002; 10.01.05.010; 06.08.03.017--
Petechiae24.07.06.004; 23.06.01.003; 01.01.03.002--Not Available
Pharyngeal oedema23.04.01.016; 22.04.05.003; 10.01.05.016--Not Available
Phlebitis24.12.03.004; 12.02.01.002--
Photophobia17.17.02.006; 06.01.01.004--
Pruritus23.03.12.0010.001970%
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Purpura24.07.06.005; 01.01.04.003; 23.06.01.004--
Pyrexia08.05.02.003--
Rash23.03.13.0010.012879%Not Available
Rash erythematous23.03.13.029--Not Available
Rash follicular23.03.10.001--Not Available
Rash macular23.03.13.003--Not Available
Rash maculo-papular23.03.13.004--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages